These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1385877

  • 1. Enhancement of rotational behavior induced by repeated administration of SKF38393 in rats with unilateral nigrostriatal 6-OHDA lesions.
    Matsuda H, Hiyama Y, Terasawa K, Watanabe H, Matsumoto K.
    Pharmacol Biochem Behav; 1992 Jun; 42(2):213-8. PubMed ID: 1385877
    [Abstract] [Full Text] [Related]

  • 2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Jun; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 4. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 5. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M, Takata K, Yanagisawa D, Ashihara E, Tooyama I, Shimohama S, Kitamura Y.
    Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
    [Abstract] [Full Text] [Related]

  • 6. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 7. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 04; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 8. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA, Mitrovic I, Battaglia G, Napier TC.
    Exp Neurol; 2004 Apr 04; 186(2):145-57. PubMed ID: 15026253
    [Abstract] [Full Text] [Related]

  • 9. [Comparative studies on antiparkinsonian agents, talipexole and bromocriptine, evaluated by contralateral rotational behavior in unilaterally nigral-lesioned rats].
    Hironaka N, Kohno Y, Yanagita T.
    Nihon Yakurigaku Zasshi; 1998 Oct 04; 112(4):257-66. PubMed ID: 9866843
    [Abstract] [Full Text] [Related]

  • 10. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Fink JS.
    Brain Res; 1996 Dec 16; 743(1-2):124-30. PubMed ID: 9017239
    [Abstract] [Full Text] [Related]

  • 11. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
    Tseng KY, Riquelme LA, Belforte JE, Pazo JH, Murer MG.
    Eur J Neurosci; 2000 Jan 16; 12(1):247-56. PubMed ID: 10651879
    [Abstract] [Full Text] [Related]

  • 12. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
    Sun BC, Zhang XX, Jin GZ.
    Life Sci; 1996 Jan 16; 59(4):299-306. PubMed ID: 8761001
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM, Marin C, Susel Z, Chase TN.
    Eur J Pharmacol; 1993 Jun 04; 236(3):385-93. PubMed ID: 8102970
    [Abstract] [Full Text] [Related]

  • 14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D, Bonito-Oliva A, Ledonne A, Nisticò R, Castelli V, Giorgi M, Sancesario G, Fisone G, Berretta N, Mercuri NB.
    Neuropharmacology; 2014 Jan 10; 76 Pt A():127-36. PubMed ID: 23973317
    [Abstract] [Full Text] [Related]

  • 17. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 10; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 18. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 10; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 19. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.
    Strömberg I, Bickford-Wimer P.
    Brain Res; 1991 Nov 15; 564(2):279-85. PubMed ID: 1687374
    [Abstract] [Full Text] [Related]

  • 20. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP, Zhou LW, Weiss B.
    J Pharmacol Exp Ther; 1994 Dec 15; 271(3):1462-70. PubMed ID: 7996459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.